Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -66,458 | -55,355 | -40,784 | -19,658 | -61,183 |
| Depreciation Amortization | 5,845 | 4,936 | 4,035 | 2,034 | 5,800 |
| Income taxes - deferred | -175 | -118 | -47 | -22 | -44 |
| Accounts payable and accrued liabilities | -2,202 | -1,854 | -813 | -1,155 | 898 |
| Other Working Capital | -359 | -3,797 | -2,335 | -137 | 2,601 |
| Other Operating Activity | 15,370 | 12,451 | 6,933 | 4,036 | 22,988 |
| Operating Cash Flow | $-47,979 | $-43,737 | $-33,011 | $-14,902 | $-28,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 416 | 414 | -37 | -5 | -892 |
| Investing Cash Flow | $416 | $414 | $-37 | $-5 | $-892 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2 | 2 | 2 | 2 | 2,163 |
| Financing Cash Flow | $2 | $2 | $2 | $2 | $2,163 |
| Exchange Rate Effect | 7,013 | 6,595 | 8,430 | 3,084 | -2,021 |
| Beginning Cash Position | 112,400 | 112,400 | 112,400 | 112,400 | 142,090 |
| End Cash Position | 71,852 | 75,674 | 87,784 | 100,579 | 112,400 |
| Net Cash Flow | $-40,548 | $-36,726 | $-24,616 | $-11,821 | $-29,690 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,979 | -43,737 | -33,011 | -14,902 | -28,940 |
| Capital Expenditure | -37 | -37 | -37 | -5 | -892 |
| Free Cash Flow | -48,016 | -43,774 | -33,048 | -14,907 | -29,832 |